Mitigating Nephrotoxicity Risks and Ranking Drug Candidates Using MALDI Mass Spectrometry Imaging: A Case Study

Bingming Chen1, Lisa LaFranco-Scheuch1, Shuzhi Dong1

  • 1Merck & Co., Inc., Rahway, New Jersey, USA.

Toxicologic Pathology
|February 27, 2025
PubMed
Summary

Drug-induced kidney damage is a significant hurdle in drug development. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) helps predict and prevent this by mapping drug distribution in kidneys.